The glucagon-like peptide 1 analogue, exendin-4, attenuates the rewarding properties of psychostimulant drugs in mice. [PDF]
Egecioglu E, Engel JA, Jerlhag E.
europepmc +1 more source
The glucagon-like peptide 1 analogue Exendin-4 attenuates the nicotine-induced locomotor stimulation, accumbal dopamine release, conditioned place preference as well as the expression of locomotor sensitization in mice. [PDF]
Egecioglu E, Engel JA, Jerlhag E.
europepmc +1 more source
Further characterization of the GlyT-1 inhibitor Org25935: anti-alcohol, neurobehavioral, and gene expression effects. [PDF]
Lidö HH +4 more
europepmc +1 more source
The Anorexigenic Peptide Neuromedin U (NMU) Attenuates Amphetamine-Induced Locomotor Stimulation, Accumbal Dopamine Release and Expression of Conditioned Place Preference in Mice. [PDF]
Vallöf D +3 more
europepmc +1 more source
Targeted deletion of Vglut2 expression in the embryonal telencephalon promotes an anxiolytic phenotype of the adult mouse. [PDF]
Nordenankar K +2 more
europepmc +1 more source
Central administration of the anorexigenic peptide neuromedin U decreases alcohol intake and attenuates alcohol-induced reward in rodents. [PDF]
Vallöf D +4 more
europepmc +1 more source
Adenosine A1 receptors contribute to immune regulation after neonatal hypoxic ischemic brain injury. [PDF]
Winerdal M +5 more
europepmc +1 more source
Overexpressing the novel autocrine/endocrine adipokine WISP2 induces hyperplasia of the heart, white and brown adipose tissues and prevents insulin resistance. [PDF]
Grünberg JR +17 more
europepmc +1 more source
Ghrelin increases intake of rewarding food in rodents. [PDF]
Egecioglu E +10 more
europepmc +1 more source
Preclinical profile of ITI-214, an inhibitor of phosphodiesterase 1, for enhancement of memory performance in rats. [PDF]
Snyder GL +13 more
europepmc +1 more source

